Abstract
Objective
To analyze the variation in breast cancer incidence, with stratification into ten-year age groups, 17 years after the nuclear accident in Goiânia.
Methods
Between 1988 and 2003, 3312 new cases were recorded. The crude and standardized incidence rates were calculated. ANOVA was used to obtain the coefficient of determination (R2) for the incidence over the course of the years, and p-values were obtained both by linear and by polynomial regression.
Results
The increases in crude and standardized incidence were statistically significant in all age groups, except for women between 20 and 29 years old. For the age group from 30 to 49 years, the increase in incidence was around 100% (p = 0.001), and from 50 to 59 years, 277% (p < 0.001). More modest increases of around 50% were observed in the age groups from 60 to 79 years (p = 0.013). For the women aged 80 years and over, the increase was 272% (p = 0.015).
Conclusions
There were significant increases in the crude and standardized incidence rates for breast cancer in the city of Goiânia. The women in the age group from 50 to 59 years were the ones who presented the highest increase in incidence. More wide-ranging epidemiological studies therefore become necessary for defining the factors that are possibly related to this excessive increase in breast cancer incidence, in certain specific segments of the female population.
Similar content being viewed by others
References
Abeloff MD, Wolff AC, Wood WC, Mccormick B, Weber BL (2004) Cancer of the breast. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG (eds) Clinical oncology, 3rd edn. Elsevier, Philadelphia, pp 2369–2470
Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA (2005) Global trends in breast cancer incidence and mortality 1973–1997. Int J Epidemiol 34:405–412
Barratt A, Howard K, Irwig L, Salkeld G, Houssami N (2005) Model of outcomes of screening mammography: information to support informed choices. Br Med J 330:936–941
Parkin DM, Bray FI, Ferlay J, Pisani P (2005) Global Cancer Statistics, 2002. CA Cancer J Clin 55:74–108
Suzuki T, Toi M, Saji S et al (2006) Early breast cancer. Int J Clin Oncol 11:108–119
Ziegler RG, Hoover RN, Pike MC et al (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85:1819–1827
Mcgregor DH, Land CE, Choi K et al (1977) Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950–69. J Natl Cancer Inst 59:799–811
IAEA—International Atomic Energy Agency (1988) The radiological accident in Goiania. Vienna, STI-PUB 815, 1988
Freitas NMA, Freitas R Jr, Curado MP et al (2006) Tendência da incidência e da mortalidade do câncer de mama em Goiânia: análise de 15 anos (1988–2002). Rev Bras Mastol 16:17–22
Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37:S4–S66
Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (2002) Cancer incidence in five continents, vol VIII. International Agency for Research on Cancer, Lyon
Paulinelli RR, Freitas R Jr, Curado MP, Souza AA (2003) A situação do câncer de mama em Goiás, no Brasil e no mundo: tendências atuais para a incidência e a mortalidade. Rev Bras Saúde Matern Infant 3:17–24
Curado MP, Latorre MRDO (2000) Câncer em Goiânia: tendências (1988–1997). Max Gráfica, Goiânia
Pereira MG (2000) Epidemiologia teoria e prática. 4ª reimpres. Guanabara Koogan, Rio de Janeiro
IBGE—Instituto Brasileiro de Geografia e Estatística. Diretoria e Pesquisa. Departamento de População e Indicadores Sociais. População residente—Censo 2000: Brasil, unidades da federação e municípios, 2000. Available at: http://www.ibge.gov.br/ (2007; Jun 26)
Segi M (1960) Cancer mortality for selected sites in 24 countries (1950–57). Tohoku University of Medicine, Sendai, Japan
Jemal A, Rebecca S, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106–130
Kerlikowske K, Grady D, Rubin SM et al (1995) Efficacy of screening mammography. A meta-analysis. JAMA 273:149–154
Shapiro S, Venet W, Strax P et al (1985). Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening. Natl Cancer Inst Monogr 67:65–74
Sondik EJ (1994) Breast cancer trends. Incidence, mortality, and survival. Cancer 74:995–999
Taplin SH, Ichikawa L, Buist DSM, Seger D, White E (2004) Evaluating organized breast cancer screening implementation: the prevention of late-stage disease? Cancer Epidemiol Bio Prev 13:225–234
Collaborative Group On Hormonal Factors In Breast Cancer (2002) Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50.302 women with breast cancer and 96,973 women without the disease. Lancet 360:187–195
Minami Y, Ohuchi N, Fukao A et al (1977) Risk factors for breast cancer: a case–control study of screen-detected breast cancer in Miyagi prefecture, Japan. Breast Cancer Res Treat 44:225–233
Lahmann PH, Hoffmann K, Allen N et al (2004) Body size and breast cancer risk: findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 111:762–771
Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G (2005) Breast cancer. Lancet 365:1727–1741
Russo J, Russo IH (1993) Development pattern of human breast and susceptibility to carcinogenesis. Eur J Cancer Prev 2(suppl 3):85–100
Barros ACSD (2006) Genética, biologia molecular e carcinogênese mamária. Rev Bras Mastol 16:78–85
Beral V (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419–427
Milanese TR, Hartmann LC, Sellers TA et al (2006) Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 98:1600–1607
Writing Group For The Women’s Health Initiative Investigators (2002) Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333
Million Women Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419–427
Ravdin PM, Cronin KA, Howlander N, Chlebowski RT, Berry DA (2006) A sharp decrease in breast cancer incidence in the United States in 2003. Breast Cancer Res Treat 100(suppl 1):S6
Wei F, Miglioretti DL, Connelly MT et al (2005) Changes in women’s use of hormones after the Women’s Health Initiative estrogen and progestin trial by race, education, and income. J Natl Cancer Inst Monogr 35:106–112
Clarke CA, Glaser SL (2006) Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol 24:e49–e50
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Freitas-Junior, R., Freitas, N.M.A., Curado, M.P. et al. Variations in breast cancer incidence per decade of life (Goiânia, GO, Brazil): 16-year analysis. Cancer Causes Control 19, 681–687 (2008). https://doi.org/10.1007/s10552-008-9131-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-008-9131-z